Supernus Pharmaceuticals reported $34.11M in Operating Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbott ABT:US $ 1342M 767M
Adamas Pharmaceuticals ADMS:US -9155000 370K
Aerie Pharmaceuticals AERI:US $ -31.5M 2.72M
Ani Pharmaceuticals ANIP:US $ -15553000 18.6M
Aphria Inc APH:CN C$ -68313000 25.11M
Bristol Myers Squibb BMY:US $ 1715M 36M
Canopy Growth Corp WEED:CN C$ -190050000 42.52M
Cara Therapeutics CARA:US $ -30876000 7.32M
Corcept Therapeutics CORT:US $ 31.94M 12.3M
Eisai 4523:JP Y 55407M 61332M
Eli Lilly And LLY:US $ 1403.4M 248.1M
Endo International Ordinary Shares ENDP:US $ 143.1M 39.58M
Gw Pharmaceuticals GWPH:US $ -21.03M 1.78M
Horizon Pharma HZNP:US $ 138.51M 298.53M
JAZZ PHA JAZZ:US $ -69.59M 231.71M
Lannett LCI:US $ -33.83M 36.67M
Marinus Pharmaceuticals MRNS:US $ -23.48M 3.68M
Pacira Pharmaceuticals PCRX:US $ 34.84M 15.41M
Perrigo Ordinary Shares PRGO:US $ -125.9M 177.3M
Pfizer PFE:US $ 5914M 397M
Revance Therapeutics RVNC:US $ -70337000 325K
Supernus Pharmaceuticals SUPN:US $ 34.11M 20.9M
Teva Pharmaceutical Industries TEVA:US $ 582M 148M
United Therapeutics UTHR:US $ 219.9M 284.7M
Xeris Pharmaceuticals Inc XERS:US $ -25787000 9.05M